Objective: to investigate whether the benefits related to a geriatric day hospital programme exceeded the costs, using a cost-benefit analysis based on changes in functional autonomy. Design: a quasi-experimental design with a historical cohort as comparison group. Setting: the geriatric day hospital programme at the Sherbrooke Geriatric University Institute in the Province of Quebec, Canada. Subjects: 151 geriatric day hospital patients. Methods: after admission to and at discharge from the geriatric day hospital programme, functional autonomy was assessed by a trained nurse using the Functional Autonomy Measurement System. Based on financial reports, costs associated with resources consumed at the geriatric day hospital programme by each subject were established. The benefit in dollars per day was estimated with a societal perspective through regression equations based on functional autonomy changes related to the geriatric day hospital programme. A model for spreading the benefit per day was proposed: the median time to institutionalisation or death. Results: for every dollar invested in the geriatric day hospital programme, the benefit for the health system was $2.14 (95% confidence interval: $1.72-$2.56). Conclusion: based on our sample of Sherbrooke Geriatric University Institute patients, the benefit related to the geriatric day hospital programme seems to exceed the costs.
Introduction
The ageing population is an important factor contributing to the cost of health care in the industrialised world. For example, elderly people accounted for 41% of public health care expenses in the Province of Quebec although they represented only 11% of the total population [1] . This reality is a challenge for current public health care systems. Given the economic constraints facing health care systems, geriatric day hospitals (GDH) constitute a partial answer to the escalating demand for institutional care and services.
Despite the popularity of GDH programmes throughout North America over the last decade [2] , little is known about their effectiveness. Studies on the effectiveness [3] [4] [5] [6] [7] and costs [5, [8] [9] [10] [11] [12] are often contradictory, and it is therefore difficult to make a judgement regarding the cost-effectiveness of GDH. In this context, the objective of this study is to implement an economic evaluation based on a cost-benefit analysis.
Methods
The day hospital programme is already implemented with a very short waiting time. It was therefore unethical to use an experimental design, and a quasi-experimental design with a historical cohort as comparison group was applied.
The GHD programme of the Sherbrooke Geriatric University Institute (SGUI) in the Province of Quebec, Canada, has a capacity of 25 patients per day. A multidisciplinary team uses a holistic approach to try to maximise the potential of elderly individuals affected by a decline in functional autonomy. The programme offers a wide spectrum of care delivered by a multidisciplinary team composed of physicians, nurses, occupational therapists, physiotherapists, speech therapists, neuropsychologists, gerontopsychiatrists, dieticians and social workers.
The study group comprised all elderly people admitted to the GDH programme between 1 April, 1998 and 31 March, 1999 (n=171) .
In order to identify two estimates of the general population of elderly people required in the present study (the natural decline of functional autonomy over time and the median time to institutionalisation or death), we drafted a comparison group from a previous longitudinal study [13] which tracked autonomy changes in elderly people. This previous study used a representative sample of community-dwelling individuals over 75 years of age (n=607), living in Sherbrooke (Quebec, Canada). This comparison group was created by matching a subject from this previous study to each GDH patient of the study group on gender, age categories (75-79 and 80q) and Functional Autonomy Measurement System (SMAF) scores ("2) at outset.
Clinical measure
The clinical measure used to estimate the benefits of the GDH programme in terms of changes in functional autonomy was the SMAF [14] . The SMAF must be administered by a trained health professional who scores the individual after questioning the subject and relatives, observing or testing the subject on 29 functions scored from 0-3 for a total score of 87. Its reliability and validity have been tested in numerous studies [14] [15] [16] [17] .
Functional autonomy was assessed by a trained nurse using the SMAF on admission to and discharge from the GDH programme. For the comparison group, the SMAF was also administered by a trained nurse at the beginning of the study and one year after the initial interview.
Estimation of costs related to the GDH programme
Four information sources were used for estimation of costs. First, the Monthly Financial (MF) report completed at the end of each month gives information by activity centre regarding the cost of salaries, employee benefits and furniture. This report is used to track the budget of all activity centres. Second, compilation of the 12 MF reports constitutes the Annual Financial report (AS-471). This report is recognised by the Ministry of Health of the Province of Quebec as the accounting system for all public health establishments. It presents subcategories of costs by activity centre. Third, the Cost Allocation by Programme (CAP) report gives the distribution of total costs for each of the five SGUI care programmes and the research centre [18] . This report is constructed from the AS-471 where different distribution keys are used to assign an activity centre cost to each SGUI programme. Fourth, a Daily Statistics (DS) report completed by health professionals reporting minutes of patient care was used in some specific situations, such as the actual time spent caring for a GDH patient.
Direct costs associated with resources consumed by the GDH programme were estimated. They were divided into two categories: general costs and specialised costs. The detailed methodology is described elsewhere [19] . General costs include four subcategories: costs related to the GDH unit (administration, staff, services related to patient care and furniture), support services, and administrative support. Specialised costs relate to specialised health professionals caring for specific patients. Items included in each category are described in Table 1 . Moreover, indirect costs related to the GDH programme are also taken into account. Indirect costs are those charged to the elderly at each GDH visit. They are related to transportation and lunch.
For the general costs category, the cost per visit ($/visit) to the GDH programme was calculated. In this method, the four subcategories of general costs were added and then divided by the total number of visits to the GDH programme for the time period under study (6,315 visits) . Two different estimation methods were used for specialised costs. For staff caring for specific patients, the average salary per hour ($/hour) for each category of health professional was calculated using the MF report. For the group of staff caring sporadically for some patients, the costs for patient X were estimated using real costs for consultations charged to the provincial health system multiplied by the number of consultations done. The total cost for patient X was established by adding direct costs (general and specialised costs) and indirect costs.
Estimation of the benefit related to the GDH programme
The benefit estimation method is based on a previous study [20] . Results showed relationships between disability score (SMAF), nursing time and cost (expressed in 1995 Canadian $/day) in relation to different living settings. The results are expressed by the regression equation:
Log (Cost=day related to a specific level of functional autonomy)1 3:368z0:042 SMAF|0:88 where 3.368q0.042 SMAF is the regression equation showing the relation between the SMAF score and the 1995 $ cost/day to take in charge the elderly person at this level of functional autonomy, and 0.88 is a correction for the urban area.
Based on the regression equation from this previous study, the benefit of the GDH programme was calculated on the difference in the costs associated with functional autonomy at discharge (SMAF T 1 ) and at admission to the programme (SMAF T 0 ). Moreover, this difference related to functional autonomy changes (SMAF T 1 -SMAF T 0 ) has to be adjusted to take into account the natural decline in functional autonomy during the time interval of the GDH programme. Using the natural decline over time measured with the SMAF observed in the comparison sample (2.9 SMAF/year), it is thus possible subsequently to adjust the SMAF T 1 -SMAF T 0 of each GDH patient to take into account the natural decline in functional autonomy during the time period of the GDH programme (SMAF T 1 adjusted -SMAF T 0 ). For example, if the length of stay of patient X is 14 weeks, we can postulate that the specific natural decline of functional autonomy for this subject is 0.78 point on the SMAF: 2.9/year=0.78/14 weeks. Equation 1, adapted from Hébert et al. [20] , gives the benefit in 1995 Canadian dollars per day related to autonomy changes for patient X, adjusted for the natural decline during his/her length of stay in the GDH programme.
Equation 1: Benefit of the GDH programme adjusted for the natural decline in functional autonomy during the time period of the GDH programme (in 1995 Canadian $/day) [20] . where T 1 adjusted =SMAF score at discharge from the GDH programme adjusted for the natural decline in functional autonomy during the time period of the GDH Cost-benefit analysis of geriatric day hospital programme and T 0 =SMAF score at admission to the programme.
This equation means that the benefit associated with the GDH programme is calculated by cost associated with the SMAF at the end of the GDH programme (3.368q0.042 SMAF T 1 adjusted 30.88) minus the cost associated with the SMAF admission (3.368q0.042 SMAF T 0 30.88).
In order to take into account the differential timing of costs between the collection of data related to the benefit estimation (1995) and the estimation of costs in this study (1998), the total benefit is multiplied by 5.59% [21] which corresponds to the cumulative inflation rate over this 3 years period.
Knowing the benefit in dollars per day related to the GDH programme, the next step was to determine the period over which this benefit has to be spread. To answer this question, we propose a model which assumes that the patient benefits from the change in functional autonomy from the discharge of GDH programme until institutionalisation or death. To estimate this time interval, survival analysis of the comparison group to institutionalisation or death is used. The median survival time in years was used as the spreading time of the benefit.
Data analysis
Descriptive statistics for the GDH sample and the comparison group are presented first. A t-test for independent samples was performed to investigate differences for age and SMAF at T 0 . Median time to death or institutionalisation for the comparison group was calculated using Kaplan-Meir survival curves. General and specialised costs were calculated and added to give the total cost. The benefits in dollars per day per patient, spreading of the benefit in days, total benefit for the sample and benefit by diagnostic category are presented. Mean, standard deviation (SD), median and semi-interquartile interval (semi-IQ) are used to describe total costs and total benefit. Cost-benefit is expressed by the difference between costs and benefit, and by the cost/benefit ratio. A 95% confidence interval (CI) was estimated for this ratio using the Taylor linearization technique for variance estimation [22] .
Results

Samples
Complete data were collected for 151 of the 171 patients included in the study at T 0 . Twenty subjects refused to be included in the study.
These 151 participants were matched with elderly people from a previous study to create the comparison group. Despite the matching process, this comparison group was slightly but significantly older (P=0.001) and less disabled (P=0.001) than the GDH sample at baseline ( Table 2 ). The effect of the GDH programme on functional autonomy is shown by the SMAF score improvement (À3.1) from T 0 to T 1 for the GDH sample. The natural decline in functional autonomy observed in the comparison sample for a one-year period is represented by an increase of 2.9 points on the SMAF score.
The diagnostic categories of the 151 GDH patients are shown in Table 3 . Their average length of stay in the GDH programme was 15.6 (SD: 7.7) weeks and the average number of visits per patient was 28.9 (SD: 5.2).
Costs
A description of general costs of the GDH programme is presented in Table 4 . Summarising the four subcategories of general costs ($1,127,332) gives a cost/visit of Table 5 . The total for the two subcategories is $218,372. Table 6 shows the total costs for the GDH sample. The total costs were established at $1,021,681 for the 4,358 visits of the 151 patients. The mean cost per subject was $6,766 (SD: $3,584) and the median was $6,090 (semi-IQ: $6,215).
Benefit estimation
From Equation 1, the $/day related to the functional autonomy change of SMAF T 1adjusted -SMAF T 0 was calculated for each patient. The median time to institutionalisation or death in the comparison group was 51 months or 1,551 days (Figure 1 ). The benefit per patient was calculated using the 1998 $/day figure for the difference in costs associated with SMAF T 1adjusted -SMAF T 0 multiplied by the number of days of the spreading period of benefit (1,551 days). Total benefit for the whole sample was established by summarising the benefit per patient of the 151 patients: the total is $2,183,077. The mean was $14,457 (SD: $18,978) and the median was $7,775 (semi-IQ: $12,659). Table 7 shows the cost-benefit analysis for the whole sample. The results show that for each dollar invested in the GDH programme, the benefit for society is $2.14 (95% CI: $1.72-$2.56).
Relation between costs and benefit
Discussion
The objective of this study was to use a cost-benefit analysis to investigate whether the benefit related to a GDH programme exceeded the costs. Our results show that the benefit exceeds costs: $2.14 (95% CI: $1.72-$2.56) to $1. Because this study is the first to use a costbenefit analysis of a GDH, it is impossible to compare our results with those from previous studies. Can we trust these results? The validity of the method must be discussed for cost and benefit estimates. First, the validity of the cost estimation was very high since the GDH programme and the health system in general are publicly funded in Quebec. The MF and AS-471 used to estimate general costs are widely verified by independent accounting. The method used to estimate the costs of health personnel caring for specific patients was very precise since health professionals must file statistics about the time spent with each patient on a daily basis. Cost estimation for specialist consultations is also very precise because it uses the physician billing system used in the Province of Quebec.
The validity of the benefit estimation was also very good. This study was conducted in the same country as Hébert et al. [20] , meaning that the specific structures of health care services and costs are identical. Moreover, to counteract the different timing of cost estimations between Hébert et al. [20] and the present study, the benefit estimations used in this study were adjusted to 1998 dollars. Cost-benefit analysis of geriatric day hospital However, the comparison group used for this study was a historical cohort and not a true control group derived from randomisation. Therefore, the equivalence of the two groups could be challenged. But it is probable that such a historical cohort was more medically stable than the subjects admitted to the GDH programme and therefore the natural functional decline over time used in this study was underestimated. In fact, the comparison group was older and less disabled than the study group. On the other hand, this could have generated an overestimation of the survival time at home and the spreading period for the benefit. Finally, since this study only estimates the benefit related to functional autonomy changes, it should be considered as the lower limit of potential benefits from a GDH programme. Other important aspects such as improvement in cognitive function, socialisation, well-being, etc., cannot be estimated in terms of dollar benefits.
Conclusion
Based on our results, we can answer the question ''Do the benefits related to the GDH programme exceed the costs?'' In our convenience sample composed of elderly people living at home and presenting an average functional autonomy score of 17.9 on the SMAF scale and admitted to the SGUI-GDH programme, the benefit outweighed costs by 114% ($1 dollar invested=$2.14 of benefit). This estimate relies only on functional autonomy changes and must be viewed as the lower limit of the global benefit of the GDH programme. Other studies should be done to duplicate our results to compare the benefit related to a GDH with the benefit related to a different intervention.
Key points
. Despite the popularity of geriatric day hospital programmes over the last decade, little is known about their effectiveness. . As the result of a previous study, it is now possible to quantify in dollars the benefit of a geriatric day hospital based on functional autonomy changes. . The results of this cost-benefit analysis showed that the benefits related to a Geriatric Day Hospital programme exceeded the costs.
